Download ![]() |
< Back |
31 Jan 2023 | |
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Standalone Unaudited Financial Results along with limited review report of the Company for the quarter ended December 31, 2022. | |
View all announcements for RUBRA MEDICAMENTS LTD. | Source: BSE India |